Skip to main content
. 2023 Apr 6;9(6):825–834. doi: 10.1001/jamaoncol.2023.0161

Figure 3. Analysis of Progression-Free Survival According to Key Patient Subgroups.

Figure 3.

Data are from an exploratory, unstratified Cox proportional hazards regression. Stages are according to American Joint Committee on Cancer criteria. To convert prostate-specific antigen (PSA) level to micrograms per liter, multiply by 1.0. Squares indicate hazard ratios, with horizontal lines indicating 95% CIs.